We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 41
Most popular |Most recent


Top 10 steps global life sciences companies should take in 2014

USA - February 24 2014 Prepare now for difficult-to-defend challenges to biological patents. Most innovative biological product companies have little experience with the...

Scott Bass, James C. Stansel, Torrey Cope.


DOJ Announces Important Changes to Yates Memo

USA - November 30 2018 In a speech delivered on November 29, Deputy Attorney General Rod Rosenstein announced important limitations to the policies regarding individual...

James M. Cole, Jaime L.M. Jones.


China develops new rules to simplify medical device re-registration process

China - April 1 2013 China's newly restructured food and drug regulatory agency, the China Food and Drug Administration ("CFDA"), has published new draft rules to...

Scott Bass, James C. Stansel, Michael W. Davis, M. Patricia Thayer, David J. Zampa.


Reimbursement woes continue for diagnostic clinical laboratories

USA - October 4 2013 On September 30, 2013, the Centers for Medicare and Medicaid Services (CMS) released the long-awaited "final" regional gap-fill reimbursement rates...

Richard D. Raskin.


Top 10 steps global life sciences companies should take in 2013

USA - March 1 2013 Engage in US budget and deficit reduction process. As governments, including the US and China, search for the means to fund priorities or reduce...

Scott Bass, James C. Stansel, Michael W. Davis, M. Patricia Thayer, David J. Zampa.